Temp Add

Piramal Healthcare May Acquire US Based Cambridge Major

By : Ahemad Shaikh | 18 June 2012
Industry : Healthcare

Piramal Healthcare is planning to acquire U.S.-based Cambridge Major Laboratories Inc, a contract drug manufacturer for $200 Mn.

Cambridge Major Laboratories makes pharmaceutical intermediates and active pharmaceutical ingredients that are used in drugs. It owns three facilities in the U.S. and one in Europe.

Recently, Piramal completed the acquisition of US based Decision Resources LLC, a health information-management company for $635 Mn.

It has also acquired the molecular imaging development portfolio of Bayer Pharma AG.

Piramal Healthcare retained Contract research and manufacturing services, smaller over-the-counter and the critical-care products segments businesses, when it sold its domestic drug formulations and diagnostic services arms to Abbott for $3.72Bn in 2010. The company is planning to use this fund for scaling up its retained businesses.

Piramal has built its pharmaceuticals empire with 25 takeovers in two decades.

Piramal Healthcare On BSE


To Read More On Piramal Healthcare.

Readers' Comments Post a Comment >>
 

KVEZAR VIEW

  DEAL TRACKER FOR
DateTransactionTypeBuyerSize ($mn)
2012-06-18  Cambridge Major - Piramal Healthcare M&A  Piramal Enterprises Limited
 
200.00 
 
  Recent Transactions In The Sector
DateTypeBuyerTargetSize ($mn)State
15/03/2013   M&A   Fresenius Kabi India Private Limited   Goa Manufacturing Unit   36.74   Completed  
01/03/2013   M&A   Mylan Inc   Agila Specialties Private Limited   1600.00   Completed  
21/02/2013   M&A   Mylan Laboratories Limited   Unit - VI (Andhra Pradesh)   32.01   Completed  
20/02/2013   M&A   IMCD Group   Indchem International   -   Completed  
 
  Profiles

Company

NamePromotersOfficeCompetitorWebsite
Piramal Enterprises Limited  Piramal Group   Piramal Tower, Ganpatrao Kadam Marg Lower Parel   Novartis India Limited
Thyrocare Technologies Limited
Ankur Drugs And Pharma Limited  
piramalhealthcare.com
Post a Comment
Display Name   E-mail  
Comment  
  Submit
Comments are moderated and generally will be posted if they are on-topic and not abusive.
News by Sector
DealCurry Via Linkedin Facebook Twitter Blackberry. BlackBerry App DealCurry on Linkedin DealCurry on Facebook DealCurry on Twitter DealCurry Rss
Latest
e-Newsletter
Real Time Web Analytics